Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Cisplatin-induced Ototoxicity in Head and Neck Cancer
NCT03400709Completed
- Sponsor
- Hospital San Juan de Dios
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of acetylcysteine in cisplatin-induced ototoxicity (2 arms), sponsored by Hospital San Juan de Dios. Primary endpoint: Hearing threshold at 3 months. Started Nov 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cisplatin-induced ototoxicity
Beyond the preview
Go deeper on NCT03400709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400709.